Report of clinical findings and treatment of twenty-four patientsA comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosaceaAcne necrotica varioliformis, resolution with isotretinoinSevere halogen acne due to a trifluoromethylpyrazole derivative and its resistance to isotretinoinThe vitamin D3 analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytesElevated ceramide levels in GH4C1 cells treated with retinoic acidXeroderma pigmentosum variant: 5 years of tumour suppression by etretinateEtretinate treatment of the nevoid basal cell carcinoma syndromeEffectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndromeRetinoids to prevent skin cancer in organ transplant recipientsBeneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipientsZur Lokalbehandlung von Keratosen mit Vitamin A-SäureChemoprevention of actinic keratoses with topical all-transretinoic acid (RA) [abstract]Preventive effect of etretinate therapy on multiple actinic keratosesClinical evaluation of topical isotretinoin in the treatment of actinic keratosesTopical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double blind, comparative study13-cis retinoic acid in the treatment of oral leukoplakiaProgressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakiaTreatment of multiple keratoakanthomas with oral isotretinoinTopical tretinoin in actinic keratosis and basal cell carcinoma13-cis retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skinEfficiency of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinomaCombination 13-cis-retinoic acid and interferon alpha 2a in the therapy of solid tumoursA phase II study of all-trans-retinoic acid in patients with metastatic melanomaPhase II study of fenretinide (n-(4-hydroxyphenylretinamide) in advanced breast cancer and melanomaPhase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanomaIsotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinateRetinoids and systemic chemotherapy in cases of advanced mycosis fungoidesThe effect of isotretinoin in six patients with cutaneous T-cell lymphomaInterferon alpha and etretinate combination treatment of cutaneous T-cell lymphomaTreatment of cutaneous T-cell lymphoma with the arotinoid Ro 13-6298Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)Risk factors promote elevations of serum lipids in acne patients under oral 13-cis-retinoic acid (isotretinoin)Treatment of mycosis fungoides with recombinant interferon-alpha 2a alone and in combination with etretinateIntramuscular low dose alpha-2b interferon and etretinate for treatment of mycosis fungoidesRoferon-A in combination with Tigason in cutaneous T-cell lymphomasThe treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-alpha 2a and etretinateSuccessful treatment of mycosis fungoides with the combination of etretinate and human recombinant interferon alpha-2aTreatment of cutaneous T-cell lymphoma with combination of low-dose interferon alpha-2b and retinoidsAll-trans retinoic acid (TRA) in the treatment of AIDS-related Kaposis sarcoma: a phase II Illinois Cancer Center study [abstract]Treatment of AIDS-associated Kaposi’s sarcoma with oral tretinoinTreatment of lichen planus with acitretin: a double-blind placebo controlled study in 65 patientsRetinoide in der Therapie des Granuloma anulare disseminatumErfolgreiche Therapie des Granuloma anulare disseminatum mit Etretinat und PrednisolonEffects of gemfibrozil (Lopid®) on hyperlipidemia in acitretin-treated patients: results of a double-blind cross-over studyEffects of isotretinoin on male reproductive systemIsotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function testsA double-blind, placebo-controlled trial of acitretin for the treatment of psoriasisSide-effect profile of acitretin therapy in psoriasisSerum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosisFish oil supplementation results in decreased hypertrigliceridemia in patients with psoriasis undergoing etretinate or acitretin therapyProspective study of skeletal changes during short-term acitretin therapyHypervitaminosis A syndrome: a paradigm of retinoid side effectsSurveillance for skeletal toxicity of children treated with etretinateBone changes and their significance in children with ichthyosis on long-term etretinate therapySkeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoinEtretinate for retinoid-responsive dermatoses: further observations of long-term therapyOsteoporosis is a toxic effect of long-term etretinate therapyArthrite aiguë au cours d’un traitement par l’isotrétinoïneLimb bud cell cultures for estimating the teratogenic potential of compounds: validation of the test system with retinoidsThe teratogenic activity of 9-cis-retinoic acid [abstract]Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenic bioassaysEar malformation in baby born to mother using tretinoin creamFirst trimester topical tretinoin and congenital disordersPercutaneous retinoid absorption and embryotoxicityTeratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral doseTeratogenic risk with etretinate and acitretin treatmentDrug administration to the pregnant or lactating woman: a reference for dermatologistsClinical pharmacology of three generations of retinoids
Retinoids in Dermatology Presenter : Dr. Sanjay Singh Dermatology, AIIMS 2. Retinoid concentrations in skin are rather low in contrast to subcutaneous fat tissue. 13-cis-beta-Vitamin-A-Säure und Vitamin A-Säure-aethylamidA double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasisEfficiency of acitretin in combination with UV-B in the treatment of severe psoriasisTraitément du psoriasis pustuleux par un nouveaux rétinoide aromatique (Ro 10-9359)Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trialLack of effect of acitretin on the hypoprothrombinemic action of phenprocumon in healthy volunteersAcitretin (Ro 10-1670) and oral contraceptives: interaction studyRandomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasisPhotochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison studyTreatment of psoriasis vulgaris with a combination of etretinate and hydroxyureaAcitretin (Ro 10-1670, etretin): overall evaluation of clinical studiesPersistent etretinate levels in plasma after changing the therapy to acitretinClinical evidence that acitretin is esterified to etretinate when administered with ethanol [abstract]Acitretin biotransformation into etretinate: role of ethanol on in vitro hepatic metabolismAcitretin in the treatment of severe disorders of keratinization. Topische Kombinationsbehandlung mit Corticoiden. Sinemet cr 200/50 ulotka The 8x8 tractor pulled 2 Dyson trailers and the whole had 24 wheels. ScienceDirect ® is a registered trademark of Elsevier B.V.Copyright © 1992 Kluwer Academic Publishers. This condition may be worsened by taking Doxycycline capsules • you are suspected of having syphilis. Retinoids in Dermatology. Since their introduction 15 years ago, retinoids have been increasingly used for topical and systemic treatment of psoriasis and other hyperkeratotic and parakeratotic skin disorders, keratotic genodermatoses, severe acne and acne-related dermatoses, and also for therapy and/or chemoprevention of skin cancer and other neoplasia.